P2RX1 and ischemic stroke: Therefore, targeting P2X1 receptors could constitute a novel therapeutic strategy to prevent local thromboinflammation during ischemic stroke by inhibit platelets but also amend neutrophil function to potentially alleviate reperfusion injury.